Medical Alley Q2 2023 Venture Report

 // Reports

August 21  

The Medical Alley Venture Report is a quarterly analysis of investment, M&A and other factors driving growth in Medical Alley®, the epicenter of health innovation and care®.

The Q2 2023 report includes information on:

  • Medical Alley Starts & Global highlights
  • Private and public markets activity
  • SBIR/STTR funding
  • Job growth in Medical Alley

Key takeaways:

  • Medical Alley companies continue to perform well compared to other industries, recording a 56% increase in private investments over last year, and attracting more than $1.1 billion overall in the first half of the year, 42% more than during H1 of last year. For comparison, other global and local investments are down (18% and 63% respectively).
  • Late-stage and growth rounds continue to be the main dollar drivers, but deal volume increased 35% over the previous quarter, showing signs of improvement for early stage.
  • Saluda Medical’s $150 million raise was the second largest private raise of the year only behind Gravie’s $179 million growth round from Q1.
  • Our analysis showed three secondary offerings, indicating that while public market activity may have decelerated, an accessible pool of capital remains.
  • SBIR/STTR funding dipped compared to last quarter, but the overall trend is positive.
Success message!
Warning message!
Error message!